Differentiation of Aneugens and Clastogens in the In Vitro Micronucleus Test by Kinetochore Scoring Using Automated...

Area of Science:

• Toxicology
• Genetics
• Biotechnology

Background:

• The in vitro micronucleus test (OECD TG 487) is crucial for assessing drug genotoxicity.
• Differentiating between clastogens and aneugens is vital for risk assessment due to aneugens' threshold response.
• Manual scoring of micronuclei and kinetochores is time-consuming and prone to human bias.

Purpose of the Study:

• To develop and validate a novel automated method for scoring micronuclei (MN) and kinetochores (k+) based on OECD TG 487.
• To enhance the accuracy and efficiency of genotoxicity testing for drug development.
• To establish a reliable classification system for aneugens based on kinetochore-positive micronuclei.

Main Methods:

• Developed an automated image analysis system for scoring MN and k+ in V79 cells using the cytokinesis-block method.
• Utilized nuclear counterstain and anti-kinetochore antibodies for labeling nuclei, MN, and kinetochores.
• Validated the automated method against a reference set of 14 genotoxicants, including clastogens and aneugens, comparing results with manual scoring.

Main Results:

• The automated method achieved 100% sensitivity for clastogens (5/5) and aneugens (6/6), and 100% specificity for non-genotoxicants (3/3).
• A threshold of ≥53.8% kinetochore-positive micronuclei was determined for classifying compounds as aneugens.
• The automated analysis demonstrated superior speed, throughput, and reduced human bias compared to manual microscopic analysis.

Conclusions:

• The developed automated MN plus kinetochore scoring method is highly specific and sensitive for genotoxicity testing.
• This methodology significantly improves upon manual analysis, offering faster and more objective results in drug safety evaluation.
• The ability to differentiate aneugens provides critical data for accurate risk assessment of potential drug candidates.